Company Profile
Harrington Group Ltd. (HGR) is headquartered in Perth, Western Australia with US operations based in Santa Clara California. The company is publicly listed on the Australian Stock Exchange (ASX) under the symbol "HGR" and is also quoted on the Pink Sheets in the US under the symbol “HGRLF”.
Harrington’s focus is on product development and commercialization for the corrections, law enforcement, military and counter-terrorism (homeland security) sectors.
Harrington sells it’s Sun Biomedical-branded drug screening products and services to the above markets as well as to government and commercial organisations, schools and medical facilities, and to the retail market generally. It’s marquee product is the world leading OraLine saliva drug screening product which is regarded as the most advanced saliva drug screen product on the market today.
Harrington is also developing its ShockRounds™ technology, a revolutionary concept in electrified projectiles that is intended to minimise casualties and injuries in situations such as riots, terrorism threats, crowd disturbances, etc.
MDM Group, Inc. (MDM) has a controlling interest in Harrington Group Limited. MDM is also publicly traded on the Pink Sheets in the US under the symbol "MDDM". MDM is a research and development company focused on investing in and commercializing technologies that address needs within the Homeland Defense, biodefense and security industries. See www.mdmgroupinc.com.
Stock Symbol: HGR
Options Symbol: HGRO
USA equivalent stock symbol: HGRLF
Exchange: Australian Stock Exchange
Industry: Security/Technology
Shares Outstanding: 127,868,218
Shares in Float: 44,080,042
Listed AUD$0.25 Options: 9,002,750
Shareholders: Approx. 950